Latest Sustainability In It News

Farm Pride Foods has locked in a $27.57 million financing deal with NAB, refinancing existing debt and backing key capital projects to strengthen its growth trajectory.

Jameson Resources has released a 2025 feasibility update for its Crown Mountain Hard Coking Coal Project, confirming reserves and revealing a doubling of project NPV despite inflationary cost pressures.

Orthocell has rapidly expanded its US distributor network for Remplir™, surpassing its target ahead of schedule and positioning itself for imminent sales in the $1.6 billion nerve repair market.

Macquarie Group Limited has announced a quarterly ordinary dividend of AUD 1.7124 per security on its perpetual capital notes, with a 35% franking rate and a total distribution yield of 6.79% per annum.

Acrux Limited, partnering with TruPharma, has introduced its Dapsone 7.5% Gel in the US, featuring a unique tube packaging that aims to improve patient convenience and reduce environmental impact.

QBE Insurance Group reported a robust 31% increase in net profit for 2024, declaring its highest dividend in years and outlining a confident outlook for 2025 amid ongoing global risks.

QBE Insurance Group reported robust 8% gross written premium growth in 1Q25, driven by strong momentum in North America and International markets, while managing significant catastrophe claims. The insurer reaffirmed its full-year outlook despite ongoing market challenges.

GQG Partners reported a steady increase in funds under management to US$163.6 billion as of April 30, 2025, driven by strong inflows in International and U.S. Equity strategies.

AVITA Medical reported a strong first quarter with revenues up 67% to $18.5 million, driven by expanded commercial sales and new product introductions. Despite a narrower net loss, the company faces ongoing challenges from revenue covenants and macroeconomic pressures.

AVITA Medical reveals a bold expansion plan targeting a $3.5 billion U.S. acute wound care market by 2025, driven by a multi-product portfolio and sustained revenue growth.

AVITA Medical reported a robust 67% increase in first quarter 2025 revenue, driven by new product launches and a strategic commercial overhaul, while reaffirming its full-year growth and profitability targets.

REA Group has posted robust growth in its Q3 results, driven by strong buyer demand and strategic product enhancements across its digital real estate platforms.